Sicart Associates LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 6,981 shares of the biopharmaceutical company’s stock, valued at approximately $3,925,000. Several other institutional investors have also recently […]

Natixis increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 72,180 shares of the biopharmaceutical company’s stock after purchasing an additional 2,751 shares during the period. Natixis owned approximately 0.07% of Regeneron Pharmaceuticals […]